Esperion Therapeutics, Inc. Quarterly Debt-to-equity in % from Q1 2014 to Q2 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Esperion Therapeutics, Inc. quarterly Debt-to-equity history and growth rate from Q1 2014 to Q2 2024.
  • Esperion Therapeutics, Inc. Debt-to-equity for the quarter ending June 30, 2024 was -177 %, a 1.51% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 -177 +2.71 +1.51% Jun 30, 2024
Q1 2024 -168 +22.5 +11.8% Mar 31, 2024
Q4 2023 -158 +45.9 +22.5% Dec 31, 2023
Q3 2023 -167 +63.4 +27.6% Sep 30, 2023
Q2 2023 -179 +34.6 +16.2% Jun 30, 2023
Q1 2023 -190 +20.4 +9.7% Mar 31, 2023
Q4 2022 -204 -1.35 -0.67% Dec 31, 2022
Q3 2022 -230 -19.8 -9.43% Sep 30, 2022
Q2 2022 -214 +62.1 +22.5% Jun 30, 2022
Q1 2022 -211 +337 +61.6% Mar 31, 2022
Q4 2021 -203 +2.04K +91% Dec 31, 2021
Q3 2021 -210 -1.63K -115% Sep 30, 2021
Q2 2021 -276 -968 -140% Jun 30, 2021
Q1 2021 -548 -1.02K -216% Mar 31, 2021
Q4 2020 -2.25K -2.4K -1518% Dec 31, 2020
Q3 2020 1.42K +1.31K +1205% Sep 30, 2020
Q2 2020 692 +625 +926% Jun 30, 2020
Q1 2020 472 +436 +1206% Mar 31, 2020
Q4 2019 158 +130 +455% Dec 31, 2019
Q3 2019 109 +90.5 +494% Sep 30, 2019
Q2 2019 67.5 +52.9 +363% Jun 30, 2019
Q1 2019 36.1 +21.6 +149% Mar 31, 2019
Q4 2018 28.6 +14.6 +104% Dec 31, 2018
Q3 2018 18.3 +6.02 +49% Sep 30, 2018
Q2 2018 14.6 +4.99 +52% Jun 30, 2018
Q1 2018 14.5 +8.37 +136% Mar 31, 2018
Q4 2017 14 +9.69 +226% Dec 31, 2017
Q3 2017 12.3 +9.01 +274% Sep 30, 2017
Q2 2017 9.59 +6.4 +201% Jun 30, 2017
Q1 2017 6.14 +2.97 +93.7% Mar 31, 2017
Q4 2016 4.28 +0.99 +30.2% Dec 31, 2016
Q3 2016 3.28 -0.61 -15.6% Sep 30, 2016
Q2 2016 3.19 -1.95 -37.9% Jun 30, 2016
Q1 2016 3.17 -4.22 -57.1% Mar 31, 2016
Q4 2015 3.28 -7.56 -69.7% Dec 31, 2015
Q3 2015 3.9 -7.32 -65.2% Sep 30, 2015
Q2 2015 5.14 -2.31 -31% Jun 30, 2015
Q1 2015 7.4 -2.71 -26.8% Mar 31, 2015
Q4 2014 10.9 Dec 31, 2014
Q3 2014 11.2 Sep 30, 2014
Q2 2014 7.45 Jun 30, 2014
Q1 2014 10.1 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.